IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 39 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $697,986 | +2.3% | 69,176 | +0.6% | 0.04% | +15.2% |
| Q3 2022 | $682,000 | +1.0% | 68,776 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $675,000 | 0.0% | 68,776 | 0.0% | 0.03% | -2.9% |
| Q1 2022 | $675,000 | +1.4% | 68,776 | 0.0% | 0.03% | -8.1% |
| Q4 2021 | $666,000 | 0.0% | 68,776 | 0.0% | 0.04% | -17.8% |
| Q3 2021 | $666,000 | 0.0% | 68,776 | 0.0% | 0.04% | -31.8% |
| Q2 2021 | $666,000 | – | 68,776 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |